Ticlopidine HCl/Gingko extract - Yuyu Pharma
Latest Information Update: 06 Jan 2016
At a glance
- Originator Yuyu
- Class Anti-ischaemics; Antiplatelets; Herbal medicines; Ischaemic heart disorder therapies
- Mechanism of Action Platelet aggregation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Ischaemia; Thromboembolism